COMMUNIQUÉS West-GlobeNewswire

K2M Group Holdings, Inc. to Release First Quarter of Fiscal Year 2018 Financial Results on May 1, 2018

13/04/2018 - 19:00

LEESBURG, Va., April 13, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Vistin Pharma ASA : Call for annual general meeting

13/04/2018 - 17:50

Oslo, Norway, 13 April 2018 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the annual general meeting in Vistin Pharma, to be held on 8 May at 13:00 CET at Østensjøveien 27, Oslo. The recommendation [...]

UPDATE: Progressive Care Reports 20% Increase in Year over Year Prescriptions Filled During March 2018

13/04/2018 - 17:49

MIAMI, April 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced increased prescriptions filled and revenue for March 2018. PharmCo, LLC filled over [...]

IBA SA : Transparency notification

13/04/2018 - 17:36

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, April 13, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it [...]

IBA SA : Notification de transparence

13/04/2018 - 17:36

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 13 avril 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

Vistin Pharma ASA : Annual Report for 2017

13/04/2018 - 17:18

Oslo, Norway, 13 April 2018 The Board of Directors of Vistin Pharma ASA has on 13 April 2018 approved the Directors' report and consolidated financial statements for Vistin Pharma for 2017. The annual report for 2017 is [...]

BioPorto A/S - Annual General Meeting

13/04/2018 - 16:21

April 13, 2018 Announcement no. 8 BioPorto A/S held its Annual General Meeting today where the shareholders approved the report on the Company’s activities and adopted the 2017 Annual Report. In addition, the general [...]

Sienna Announces April Dividend

13/04/2018 - 16:00

MARKHAM, Ontario, April 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) [...]

Summit Therapeutics Files US Annual Report on Form 20F

13/04/2018 - 15:45

Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Files US Annual Report on Form 20-F Oxford, UK, and Cambridge, MA, US, 13 April 2018 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT) provides [...]

Progressive Care Reports 20% Increase in Year over Year Prescriptions Filled During March 2018

13/04/2018 - 14:15

MIAMI, April 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced increased prescriptions filled and revenue for March 2018. PharmCo, LLC filled over [...]

Calithera Biosciences to Present New Preclinical Data for CB-839 at AACR Annual Meeting 2018

13/04/2018 - 14:02

Synergy of CB-839 with CDK4/6 and PARP inhibitors SOUTH SAN FRANCISCO, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the [...]

Ceapro Inc. to Present at the 12th International Symposium on Supercritical Fluids

13/04/2018 - 14:00

EDMONTON, Alberta, April 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]

Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification

13/04/2018 - 14:00

DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD ) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal 2018. The Company [...]

CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018

13/04/2018 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Olerup QTYPE® Receives CE Mark Certification

13/04/2018 - 14:00

Fastest real time typing with Olerup QTYPE is now broadly available BRISBANE, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, [...]

BioCorRx to Participate in the First Annual Orange County Recovery Collaborative Resource Fair

13/04/2018 - 13:19

ANAHEIM, CA, April 13, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addition, today announced that the [...]

Liver Biopsy Data from POISE Phase 3 Substudy Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients

13/04/2018 - 13:00

11 of 13 patients improved or maintained histological fibrosis stage after three years of treatment with obeticholic acid (OCA) NEW YORK, April 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT [...]

EyeGate Announces $11.25 Million Public Offering

13/04/2018 - 13:00

WALTHAM, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]

Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia

13/04/2018 - 13:00

Six abstracts support lefamulin as a potential first-in-class pleuromutilin antibiotic targeting CABP pathogens, including drug resistant phenotypes DUBLIN, Ireland, April 13, 2018 (GLOBE NEWSWIRE) -- Nabriva [...]